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Abstract Neural precursor cell expressed, develop-
mentally down-regulated 9 (Nedd9, Casl, Hef1,
p105cas, Ef1) is a scaffolding protein that assembles
complexes involved in regulating cell adhesion,
migration, division, and survival. Nedd9 is found very
early in the developing embryonic nervous system. A
highly conserved complex retinoic acid response
element (RARE) is located 485 base pairs (bp)
upstream of exon 2B in the promoter of the Nedd9
gene. Mice transgenic for a 5.2 kilobase (kb) region of
the 2B Nedd9 promoter containing the RARE
upstream of a lacZ reporter gene [Nedd9(RARE)-
lacZ] show a large subset of the normal endogenous
Nedd9 expression including that in the caudal hind-
brain neuroepithelium, spinal cord, dorsal root ganglia
(drg) and migrating neural crest (ncc). However, the
transgenic mice do not recapitulate the native Nedd9
expression pattern in presumptive rhombomeres (pr) 3
and 5 of the early hindbrain, the base of the neuro-
epithelium in the midbrain, nor the forebrain telen-
cephalon. Thus, the 5.2 kb region containing the intact
RARE drives a large subset of Nedd9 expression, with
additional sequences outside of this region needed to
define the full complement of expression. When the
5.2 kb construct is modified (eight point mutations) to
eliminate responsiveness of the RARE to all-trans
retinoic acid (atRA) [Nedd9(mutRARE)-lacZ], virtu-
ally all b-galactosidase (b-gal, lacZ) expression is lost.
Exposure of Nedd9(RARE)-lacZ transgenic embryos
to excess atRA at embryonic day 8.0 (E8.0) leads to
rostral ectopic transgene expression within 6 h
whereas the Nedd9(mutRARE)-lacZ mutant does not
show this effect. Thus the RARE upstream of the
Nedd9 2B promoter is necessary for much of the
endogenous gene expression during early develop-
ment as well as ectopic expression in response to
atRA.
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Introduction
All-trans retinoic acid (atRA) is a metabolite of
vitamin A that is essential to support normal growth
and differentiation in a wide variety of cells and tissues
(Clagett-Dame and DeLuca 2002; Clagett-Dame and
Knutson 2011). It regulates many aspects of morpho-
genesis and organogenesis (Rhinn and Dolle 2012). In
the developing nervous system, atRA is required to
pattern the posterior hindbrain/anterior spinal cord
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region, and later, for neuronal differentiation (Clagett-
Dame and Knutson 2011; Gavalas and Krumlauf
2000; Glover et al. 2006). atRA acts by binding to
nuclear retinoic acid receptors (RAR). These receptors
when bound to ligand regulate the transcription of
atRA-responsive genes in a cell type and tissue-
specific manner. The RAR binds to the retinoid X
receptor (RXR), forming a heterodimer that binds with
high affinity to DNA sequences called RAREs
(Chambon 1996). Formation of the atRA-receptor
complex initiates the release of repressor proteins and
the recruitment of coactivators to the site, thus opening
up the chromatin structure and facilitating transcrip-
tional response (Samarut and Rochette-Egly 2012).
Binding of the RAR/RXR complex to these RARE
enhancer sequences is the major mechanism whereby
atRA directly regulates target gene expression (Bal-
mer and Blomhoff 2002).
The identification of target genes that play a role
downstream of atRA and its receptors in nervous
system development is an active area of investigation.
Our lab identified Nedd9 (Casl, Hef1, p105cas, Ef1) as
a gene that is rapidly induced after the exposure of SH-
SY5Y human neuroblastoma cells to atRA (Merrill
et al. 2004a, b). Nedd9 is a member of the Crk-
associated substrate (Cas) family of multidomain
docking or scaffolding proteins that lie downstream
of integrin-initiated signal transduction pathways
(Tikhmyanova et al. 2010). Cell culture studies
suggest that the NEDD9 protein influences multiple
biological processes, including regulation of cell
shape, cell migration, apoptosis and the cell cycle
(Singh et al. 2007). In response to atRA, SH-SY5Y
cells differentiate and undergo morphological
changes, including the extension of neurites and
changes in adhesion (Pahlman et al. 1984). Ectopic
overexpression of NEDD9 in PC12 (pheochromocy-
toma) cells or in MCF-7 (human breast carcinoma)
cell lines also treated with a Rho kinase inhibitor leads
to the formation of neurite-like membrane extensions
(Bargon et al. 2005; Sasaki et al. 2005) supporting the
idea that NEDD9 might participate in mediating the
effects of retinoid on neurite outgrowth and/or
changes in cell adhesion properties.
Nedd9 is expressed in the nervous system of the
developing embryo, including the early hindbrain and
spinal cord. Previously, our group showed that Nedd9
mRNA is expressed very early in the node, presump-
tive rhombomeres of the developing hindbrain,
neuroepithelium and floor plate, spinal cord, dorsal
root and cranial ganglia, and a variety of other tissues
including the otocyst, pharyngeal arches, lung, fore-
gut, kidney and cartilage primordia, and early vascu-
lature (Merrill et al. 2004a, b). Another group showed
that Nedd9 is also expressed in ventral midbrain,
diencephalon, progenitors of pontine and cerebellar
nuclei, dorsal motor nucleus of the vagus nerve, the
hypoglossal nucleus and in non-lineage-restricted
neural crest progenitor cells (Aquino et al. 2008,
2009). However, it is not known whether Nedd9 gene
expression in any of these regions is under the direct
regulation of atRA and its receptors.
A 31-bp atRA RARE is present approximately 450
bps 50 of the transcriptional start site of the 2B promoter
of the Nedd9 gene (Knutson and Clagett-Dame 2008;
Merrill et al. 2004b). The Nedd9 RARE is more
complex in structure than many RAREs that have been
reported. Classical RAREs are composed of two direct
repeats of PuG(G/T)TCA separated by a variable
number of bases; 5, 2, or 1 (Chambon 1996; Mangels-
dorf 1994), whereas binding elements with more
diverse spacing and topology have also been identified
(Al Tanoury et al. 2013). The Nedd9 RARE is
composed of four direct repeats separated by 1, 5 and
1 bps, all of which are needed for maximum induction
of a transiently transfected reporter by atRA. Regula-
tion of Nedd9 gene transcription via the direct binding
of the RAR/RXR complex to this RARE enhancer in
cultured cells was previously confirmed using ChIP
analysis (Knutson and Clagett-Dame 2008).
In the present study, transgenic reporter mice
containing approximately 5.2 kb of the Nedd9 2B
promoter with an intact RARE or with the RARE
rendered nonfunctional by eight point mutations were
generated and studied. The contribution of the RARE
to the endogenous Nedd9 spacio-temporal expression
pattern is examined, and the importance of the intact
RARE in mediating response to exogenously admin-
istered atRA is explored.
Materials and methods
Nedd9 b-galactosidase transgene constructs
The Nedd9 b-gal transgene constructs were generated
using the plasmid pUC19/AUGbgal (obtained from
Dr. Eric N. Olson, UT Southwestern) (Cheng et al.
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1992). The pUC19/AUGbgal plasmid contains an
alcohol dehydrogenase translational start codon and a
Simian Virus 40 polyadenylation sequence located at
the 30 end of the lacZ coding sequence. The plasmid
also contains the pCMVb Simian Virus 40 splice
donor/splice acceptor cassette (Clontech) 50 of the lacZ
coding sequence in order to increase lacZ expression
(Choi et al. 1991). The splice cassette, which was
generated by BspEI and XmaI restriction digest of the
plasmid pCMVb (Clontech), was ligated into a unique
XmaI restriction site in the pUC19/AUGbgal vector
prior to the addition of the Nedd9 promotor region.
The intact RARE Nedd9 plasmid (Online Resource
1a–c), ‘‘Nedd9(RARE)-lacZ’’ was constructed by ampli-
fying a 5.4 kb region (-5,366, ?15) from the human
bacterial artificial chromosome (Online Resource 1b;
BAC; RP11-263D22, CHORI; Oakland, Ca) with the
upstream primer 50-TAG TCC CAC GAG GGT GGA-30
and the downstream primer 50-ATC GTG TCG ACC
GAA CTC CGG GAA CAA AA-30, which includes an
internal SalI site that reduces the fragment to 5.2 kb. The
amplified DNA was cloned into the pGEM-T Easy
Vector (Promega), and a positive clone was verified by
restriction digest followed by sequence analysis. Next,
an SphI and SalI fragment (-5,177, ?15) was subcloned
into pUC19/AUGbgal plasmid cut at unique SphI and
SalI sites (Online Resource 1c). A positive clone was
verified first by restriction digest followed by sequence
analysis. The modified RARE Nedd9 plasmid,
‘‘Nedd9(mutRARE)-lacZ’’, was constructed by ampli-
fying a fragment containing the RARE with eight point
mutations (-842, ?15) from the hM-1/2/3/4 plasmid
described previously (Knutson and Clagett-Dame 2008)
with the upstream primer 50-AGA CGC GAA GGG
AAT CAG A-30 and the downstream primer 50-ATC
GTG TCG ACC GAA CTC CGG GAA CAA AA-30
(which also includes an internal SalI restriction site), and
cloning it into the pGEM-T Easy Vector. A positive
clone was verified first by restriction digest followed by
sequence analysis. A BstEII and SalI fragment (-842,
?15) containing the mutant RARE was then used to
replace this same region in the Nedd9(RARE)-lacZ
plasmid. A positive clone was verified first by restriction
digest followed by sequence analysis.
Prior to use for pronuclear microinjection, plasmids
were tested for atRA-regulated expression in a cell
culture system. MCF-7 cells were transfected and
assayed as previously described (Knutson and Clagett-
Dame 2008). Briefly, cells were seeded in six-well
plates and were transfected in triplicate with reporter
plasmid, pGL3-Basic (internal luciferase control), and
RAR and RXR expression plasmids using FuGENE 6
and evaluated for both b-gal and luciferase activity. b-
gal values are normalized to luciferase values. Data
shown is the average of triplicate wells ± the standard
error (Online Resource 1d).
Production and study of transgenic animals
Transgenic mice were produced by pronuclear micro-
injection of the intact RARE construct [Nedd9(RARE)-
lacZ] or modified RARE construct [Nedd9(mutRARE)-
lacZ] using NarI and SphI linearized fragments accord-
ing to established methodologies by the Roswell Park
Cancer Institute (RPCI) Gene Targeting and Transgenic
Core Facility. Transgenic founders were sent to the
University of Wisconsin-Madison. All animal studies
were performed under an approved Animal Care and
Use Committee (ACUC) animal protocol according to
institutional guidelines at the University of Wisconsin-
Madison. Treatment of mice was in accordance with
policies of the Institutional Animal Care and Use
Committees (IACUC) at both institutions.
Founder animals for each transgene were identified by
PCR genotyping of DNA isolated from tail biopsies
(Online Resource 1e). For the intact RARE construct,
Nedd9(RARE)-lacZ, two independent founder lines,
wt4966 and wt5000, were successfully established. Both
the level of b-gal staining intensity as well as the
spatiotemporal expression pattern appeared similar for
the wt4966 and wt5000 lines. Injection of the modified
RARE resulted in five independent founder lines
(mut5879, mut6636, mut6644, mut6646 and mut6653),
three of which were extensively characterized. Both the
level of b-gal staining intensity as well as the spatiotem-
poral expression pattern appeared similar for these three
mutant lines (mut5879, mut6646, and mut6653). The
staining pattern of a fourth line (mut6644) was also
similar, but was not included in the results as we were
unable to establish this line before the founder died. A
fifth mutant line was discontinued as the staining differed
from the other four lines, likely the result of positional
effects.
Embryo generation
The majority of transgenic embryos were generated by
mating male transgenic mice with female wild-type
Transgenic Res (2015) 24:123–134 125
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(WT) (C57Bl/10Ros-pd 9 C3h/HeRos) mice (389
timed matings) with a lesser number resulting from
male WT and female transgenic crosses (86 timed
matings). In all crosses, the staining pattern of the
transgenic embryos was similar for that construct at each
stage examined. Embryos were assigned embryonic day
numbers with noon on the day of vaginal plug detection
designated as embryonic day 0.5 (E0.5), 4–6 somites
(E8.25), 7–11 somites (E8.5) and 12–15 somites (E8.75).
b-galactosidase staining of mouse embryos
to analyze transgene expression
Embryos were fixed at room temperature (rt) in 4 %
paraformaldehyde for the following times; E8–9.5
(5 min), E10.5 (15 min), E11.5 (20 min) and E12.5
(30 min). Embryos were then washed at rt twice in PBS
(pH 7.2) and then rinse buffer (5 mM EGTA, 2 mM
MgCl2, 0.01 % Na deoxycholate, and 0.02 % NP-40 in
PBS) for 5 to 10 min each. Embryos were stained
(5 mM K3Fe(CN)6, 5 mM K4Fe(CN)6, 5 mM EGTA,
2 mM MgCl2, 0.01 % Na deoxycholate, 1 mg/ml
X-gal, 0.02 % NP-40 in PBS) in the dark at 37 C
overnight (*16 h). After washing in PBS for 10 min at
rt and post-fixation in 4 % paraformaldehyde overnight
at 4 C, embryos were washed again in PBS at rt for
10 min, and stored in PBS at 4 C followed by
photography using a Nikon model SMZ-U dissection
microscope fitted with a 19 lens using a SPOT digital
camera (Spotcam, Diagnostic Instruments Inc., Sterling
Heights, MI) or Qimaging camera (Qimaging, Surrey,
British Colombia) and MetaMorph software (Molecu-
lar Devices, Downington, PA). At each stage a
minimum of three embryos from five independent
litters were analyzed for each of two Nedd9(RARE)-
lacZ lines and three Nedd9(mutRARE)-lacZ lines.
In situ hybridization
A 841-bp mouse Nedd9 probe was amplified using
mRNA isolated from adult mouse lung using the
upstream primer 50-ACC GCG GTG GAC AAA GTA
GAG C-30 and the downstream primer 50-AGA GGG
CGT CGA TGG CGT TGA GTA G-30 (1,628-2,468
based on the mouse Nedd9 sequence; accession no.
NM_017464) and subcloned into pGEM-T Easy Vector
(Promega). The sequence was 99 % identical to
NM_017464 and differed at 3 non-sequential base pairs
(1,756 A to G, 1,996 C to T, and 2,087 T to C). Whole-
mount in situ hybridization was carried out using
embryos fixed in 4 % paraformaldehyde by the methods
previously described (Stern 1998; White et al. 2000;
Wilkinson 1998) with the following modifications. The
following proteinase K (pK)/refix times were used at
each stage; E8.5 (12/10 min), E9.5 (12/10 min), E10.5
(20/10 min) for embryos in whole-mount, and at E11.5
(10/8 min) for vibratome sections (200 lm). Both anti-
sense and sense probes were tested. Embryos were
imaged as described above.
Whole-mount immunohistochemistry for Krox20
Whole-mount immunohistochemistry was performed
following b-gal staining using previously described
methods (McNeill et al. 2010; Wall et al. 1992). Briefly,
embryos pretreated with H2O2 to quench endogenous
peroxidase activity were incubated with Krox20 antibody
(Covance, Princeton, NJ, USA) diluted 1:500 in TBST
(10 mM Tris, pH 8.0, 150 mM NaCl, 0.05 % Tween 20).
This was followed by incubation with anti-mouse or anti-
rabbit IgG conjugated to horseradish peroxidase (South-
ern Biotechnology Associates, Birmingham, AL, USA)
diluted 1:500 in TBST. Embryos were pre-incubated in a
solution of PBT (PBS containing 0.05 % Tween20)
containing 0.6 mg/ml 3,30-diaminobenzidine (DAB;
Sigma, St Louis, MO, USA) with 0.75 % NiCl2 in PBT
followed by the addition of H2O2 to a final concentration
of 0.03 % for color development. Krox20-stained
embryos were photographed in PBS as described above.
Retinoids and treatment of embryos with excess
atRA
All-trans retinoic acid was purchased from Spectrum
Chemical Company (New Brunswick, USA) and was
deemed greater than 99 % pure by reverse-phase high-
performance liquid chromatography (Motto et al.
1989). Female mice were given a single oral bolus
dose of atRA (50 mg/kg) in soybean oil or vehicle at
E8.0, and were euthanized 6 h later.
Results
Generation of the Nedd9 RARE-lacZ reporter mice
Transgenic reporter mice were generated and included
two independent founder lines containing the intact
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unmodified Nedd9 RARE sequence [Nedd9(RARE)-
lacZ] as well as founder lines in which the RARE was
rendered unresponsive to atRA by mutation
[Nedd9(mutRARE)-lacZ] of which three lines were
extensively characterized. Using a transfection cell
reporter assay we previously showed that a fragment
of the Nedd9 2B 50 promoter sequence (-2,756 to
?15) containing the complex RARE is responsive to
atRA (Knutson and Clagett-Dame 2008). In designing
the Nedd9 transgenic targeting constructs, the region
was extended to -5,177 to ?15 bp in order to
encompass any additional nearby sites that might be
important for transcriptional regulation in vivo
(Online Resource 1). Additional mice with the RARE
region mutated at eight positions were generated to
determine the contribution of the Nedd9 RARE to its
spatiotemporal expression pattern. Prior to injection
into fertilized oocytes, each of the targeting constructs
was tested for both b-gal activity as well as atRA
induction in a transient transfection assay (Online
Resource 1d). The intact and mutant RARE constructs
showed similar basal levels of b-gal activity. How-
ever, only the cells transfected with the construct
containing the intact RARE, Nedd9(RARE)-lacZ,
showed an increase in expression upon addition of
atRA, with no increase observed in atRA-treated cells
transfected with the mutated element, Nedd9(mut-
RARE)-lacZ.
The Nedd9(RARE)-lacZ transgene containing
the intact RARE recapitulates a large subset
of the endogenous Nedd9 mRNA expression
pattern
Nedd9 expression was examined in WT embryos by
in situ hybridization using a riboprobe designed to
detect all mRNA variants. At E8.5, WT embryos
showed staining in pr3, pr5 and in neural crest cells
(ncc) exiting pr2 of the hindbrain (Fig. 1a). Nedd9
mRNA expression was also observed in the caudal
neuroepithelium as well as in the midbrain region
(Fig. 1a). In Nedd9(RARE)-lacZ embryos b-gal stain-
ing at E8.5 was observed caudal to pr5 in the
hindbrain, with expression extending to approxi-
mately somite 7/8 of the neuroepithelium (Fig. 1b,
c). Transgene expression was also observed in
ncc exiting the hindbrain at the level of pr2 in
Nedd9(RARE)-lacZ embryos (Fig. 1b) and was appar-
ent in ncc exiting pr2, pr4, and pr6/7 at later stages
(Fig. 1d). Unlike the WT embryo, staining in pr3
and pr5, as well as the midbrain was absent in
Nedd9(RARE)-lacZ embryos (Fig. 1b).
Nedd9 mRNA expression was observed in the
telencephalon of a WT embryo at E10.5 with lighter
staining in the diencephalon. Staining in these
forebrain regions was not evident in Nedd9
(RARE)-lacZ embryos (compare Fig. 1e to 1f).
However, in both WT and Nedd9(RARE)-lacZ
embryos, staining was observed in the trigeminal
(V), facio-acoustic (VII/VIII), and vagal (X) ganglia
(compare Fig. 1e and 1f; and Fig. 1g and 1h), and b-
gal staining was evident at E10.5 in the cranial
nerves of VII/VIII, IX and X (Fig. 1i). Expression
was also observed in the neural tube in both WT and
Nedd9(RARE)-lacZ embryos at this stage, and
staining in both extended into the tail. Vibratome
sections from WT (Fig. 1j, l) and Nedd9(RARE)-
lacZ (Fig. 1k, m) embryos at E11.5 showed staining
in a number of structures of neural origin including
the neural tube and drg. The Nedd9(RARE)-lacZ
embryos also showed staining in nerves innervating
the limbs. However, Nedd9 expression in the WT
lung bud was not recapitulated in Nedd9(RARE)-
lacZ embryos. Thus, the 5.2 kb region immediately
upstream of the Nedd9 promoter containing the
RARE drives a large, but not complete, subset of the
native gene expression.
Effect of RARE mutation on embryonic transgenic
expression
In order to understand the contribution of the Nedd9
RARE to overall Nedd9 expression, transgenic lines
were generated in which the RARE was mutated making
it unresponsive to induction by atRA and its receptors
(Knutson and Clagett-Dame 2008). Four lines from
independent founders showed similar embryonic stain-
ing patterns and three of these lines were extensively
studied (Online Resource 1c). At E8.5–9, mutation of
the RARE resulted in a complete loss of stain in the
hindbrain and neural tube in all Nedd9(mutRARE)-lacZ
transgenic lines (Fig. 2). In addition, the majority of
lacZ expression in cells that had begun migrating from
the lateral edges of the anterior hindbrain (ncc) adjacent
to pr2 and pr4 at this time was also absent in the mutants.
Loss of lacZ expression in ncc and neural tube of the
mutant was also confirmed in vibratome sections
(compare Fig. 2a–c with Fig. 2d–f).
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Fig. 1 Comparison of endogenous and transgenic Nedd9
expression (a–c) Nedd9 expression at E8.5. Endogenous Nedd9
expression in a representative WT embryo as determined by
in situ hybridization (a) is compared to b-gal stained
Nedd9(RARE)-lacZ in a transgenic embryo (b). The lacZ
expression pattern in two independent transgenic lines was
similar (data not shown). An antibody to Krox20 (brown stain)
was used to confirm the location of pr3 and pr5. Analysis of a b-
gal stained Nedd9(RARE)-lacZ embryo before (b) and after
(c) immunohistochemical analysis using an antibody to Krox20.
(d) Nedd9 transgene expression at E8.75. e–i Nedd9 expression
at E10.5. Endogenous Nedd9 expression in a WT embryo as
determined by in situ hybridization (e) compared to a b-gal
stained Nedd9(RARE)-lacZ transgenic embryo (f); the region of
cranial nerve X is boxed, and enlarged for each embryo,
respectively, in (g) and (h). Nedd9 transgene expression in
cranial nerves at E10.5 (i). Sections from a WT E11.5 embryo
that was vibratome sectioned (200 lm) prior to in situ
hybridization show endogenous Nedd9 expression (j, l).
Vibratome sections (150 lm) from a E11.5 b-gal stained
Nedd9(RARE)-lacZ transgenic embryo (k, m). Scale bar is
50 lm. Abbreviations mb midbrain, ne neuroepithelium, pr3
presumptive rhomobomere 3, pr5 presumptive rhomobomere 5,
ncc pr2 neural crest cells migrating from presumptive rhom-
obomere 2, ncc pr4 neural crest cells migrating from presump-
tive rhomobomere 4, ncc pr6/7 neural crest cells migrating from
presumptive rhomobomere 6/7, ov otic vesicle, te telencepha-
lon, di diencephalon, ey eye, V trigeminal nerve, VII/VIII facio-
acoustic nerve, IX glossopharyngeal nerve, X vagal nerve, pa1
pharyngeal arch 1, pa2 pharyngeal arch 2, sc spinal cord, drg
dorsal root ganglia, nt neural tube, hl hindlimb, fl forelimb, lb
lung bud
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One day later (E9.5) the neural tube staining as
well as staining in the migrating ncc population was
absent in the Nedd9(mutRARE)-lacZ lines, whereas
both of these regions were darkly stained in the
Nedd9(RARE)-lacZ transgenics (Fig. 3a vs 3 g). Only
staining in the most caudal tail region was observed
in the mutant (Fig. 3g). The majority of staining
including that in the spinal cord and the developing
ganglia of V, VII/VIII, IX and X, as well as in the
developing spinal nerves in Nedd9(RARE)-lacZ
embryos at both E10.5 and 11.5 (Fig. 3b, c) was
absent in the Nedd9(mutRARE)-lacZ lines (Fig. 3h, i).
Nedd9(mutRARE)-lacZ lines was confined to the
caudal tail region.
To examine transgene expression internally, Nedd9
(RARE)-lacZ and Nedd9(mutRARE)-lacZ embryos
were sectioned on a vibratome. A section through the
head at the level of the eye in a E11.5 Nedd9(RARE)-
lacZ transgenic embryo showed strong staining in the
optic stalk region, as well as in the ganglia of V, VII/VIII
and in the hindbrain (Fig. 3d). The Nedd9(mutRARE)-
lacZ transgenics were devoid of stain in these areas
(Fig. 3j). At the level of the limbs, the Nedd9(RARE)-
lacZ transgenic showed lacZ expression in a number of
structures of neural origin including the entire length of
the neural tube, all drg, as well as the nerve tracts
extending from the spinal cord including the radial and
medial nerves of the both the fore- and hind-limb
(Fig. 3c, e). In the Nedd9(mutRARE)-lacZ transgenics,
neural tube and drg expression was only observed in the
last 1/3 to 2/3 of the embryo (Fig. 3k, l) and was never as
robust as in the Nedd9(RARE)-lacZ line.
Expression of the transgenic reporter in
Nedd9(RARE)-lacZ embryos is responsive
to atRA and is dependent on an intact RARE
All-trans retinoic acid signaling in the developing
nervous system is required for normal hindbrain
patterning, and this region is also adversely affected
by excess exogenous retinoid (Clagett-Dame and
DeLuca 2002). In order to determine whether the
Nedd9(RARE)-lacZ or Nedd9(mutRARE)-lacZ con-
struct respond to atRA in vivo, pregnant mice were
given a single oral dose of atRA or control vehicle at
E8.25, and the expression of the Nedd9 transgene was
bFig. 2 Characterization of the effect of RARE mutation on
transgene expression at E8.5. A representative E8.5 Nedd9
(RARE)-lacZ b-gal stained embryo in whole-mount (left), and
in vibratome sections (a–c, 60 lm thick). A representative E8.5
Nedd9(mutRARE)-lacZ b-gal stained embryo in whole-mount
(right), and in vibratome sections (d–f, 60 lm thick). Dotted
line over the embryo indicates the approximate location of the
correspondingly labeled section below. Scale bar is 50 lm. The
lacZ expression pattern in all three independent mutant lines was
similar (data not shown). The bent arrow marks the most rostral
site of neuroepithelium expression. Abbreviations ncc neural
crest cells, pr2 presumptive rhomobomere 2, pr4 presumptive
rhomobomere 4, ncc pr2 neural crest cells migrating from
presumptive rhomobomere 2, ncc pr4 neural crest cells
migrating from presumptive rhomobomere 4, pa1 pharyngeal
arch 1, ne neuroepithelium, nt neural tube, fgd foregut
diverticulum
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examined 6 h later. The vehicle treated embryos all
showed the expected transgene expression pattern for
that line (Fig. 4a, b, e, f). At the eight somite stage,
vehicle-treated Nedd9(RARE)-lacZ embryos expressed
the transgene in the neuroepithelium adjacent to the
somites, starting at the level of the otic sulcus.
Additional staining in the mesenchyme was noted just
rostral of the preotic sulcus that marks the border
between pr2 and pr3, and is consistent with transgene
expression in ncc that have just begun to delaminate
from the lateral edges of the neural plate (Fig. 4a, b). In
Nedd9(RARE)-lacZ embryos exposed to atRA, there
was ectopic transgene expression throughout the ante-
rior hindbrain neuroepithelium caudal to the pr2/3
border, as well as an increase in the number of cells
positive for stain migrating into the head region from pr2
(Fig. 4c, d). As expected, embryos carrying the mutant
RARE and treated with vehicle lacked staining in the
neuroepithelium and in ncc exiting pr2 (Fig. 4e, f), and
Nedd9(mutRARE)-lacZ embryos exposed to atRA at
E8.25 showed little additional expression compared to
the mutant vehicle control embryos (Fig. 4g, h).
Discussion
Transgenic mice with 5.2 kb of the Nedd9 promoter
containing a complex RARE and driving lacZ expression
[Nedd9(RARE)-lacZ mice] show a distribution pattern
overlapping that of the native Nedd9 mRNA in WT mice.
Both endogenous Nedd9 mRNA and lacZ expression in
Nedd9(RARE)-lacZ transgenic mice are observed in the
hindbrain epithelium caudal to pr5. At later stages,
endogenous Nedd9 mRNA as well as the expression of
the intact Nedd9(RARE)-lacZ reporter are observed in
the dorsal spinal cord, drg, and cranial nerves V, VII/VIII
and X. At early stages, Nedd9(RARE)-lacZ staining is
also observed in ncc emanating at all levels of the
hindbrain. This is consistent with the previously reported
expression of Nedd9 in non-lineage-restricted neural
crest progenitor cells (Aquino et al. 2009).
The loss of the majority of lacZ expression in
multiple independent transgenic lines with the same
5.2 kb region of the Nedd9 2B promoter in which the
RARE sequence is mutated at eight point mutations
[Nedd9(mutRARE)-lacZ] reveals the importance of
this element in mediating NEDD9 expression in vivo.
Fig. 3 Characterization of the effect of RARE mutation on
transgene expression at E9.5–E11.5 (a–f) Nedd9(RARE)-lacZ
b-gal and (g–l) Nedd9(mutRARE)-lacZ b-gal stained embryos.
Representative embryos at E9.5 (a, g), E10.5 (b, h), and E11.5
(c, i) are shown. Vibratome sections (150 lm) of the E11.5
embryo shown in (c, i); dotted lines over the embryo indicate the
approximate location of the sections (d–l). Scale bar is 50 lm.
Abbreviations ncc pr2 neural crest cells migrating from
presumptive rhomobomere 2, ncc pr4 neural crest cells
migrating from presumptive rhomobomere 4, ov otic vesicle,
V trigeminal nerve, VII/VIII facio-acoustic nerve, IX glosso-
pharyngeal nerve, X vagal nerve, ey eye, hl hindlimb, fl forelimb,
sc spinal cord, os otic sulcus, mn/rn medial and radial nerves, hb
hindbrain, drg dorsal root ganglia, nt neural tube
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Earlier work from our group in cell culture showed that
mutation of the RARE in this fashion eliminates the
response of a reporter gene to atRA (Knutson and
Clagett-Dame 2008). The complete or nearly complete
loss of reporter expression in transgenic mice carrying
the mutant RARE argues that endogenous atRA plays
an important role in regulating the expression of Nedd9.
The Nedd9 gene spans nearly 204 kb, and, the
Nedd9 gene has two distinct transcriptional and
translational start sites. The two independent promoter
regions are depicted in Online Resource 1a. The
Nedd9(RARE)-lacZ construct contains a region that
lies directly upstream of the 2B promoter region,
shown previously to be regulated by atRA (Knutson
and Clagett-Dame 2008). There are regions where
Nedd9 mRNA but not b-gal activity is observed
including pr3 and pr5 of the hindbrain, the telenceph-
alon, diencephalon, and ventral midbrain. Thus,
regulatory sequences outside of the 5.2 kb transgenic
construct are also required for normal Nedd9 expres-
sion, and it is possible these could represent expression
regulated through the alternate upstream promoter.
However, the present work clearly shows that a
majority of Nedd9 expression in early embryos is
regulated through the 2B promoter.
Many regions where Nedd9(RARE)-lacZ transgene
expression is dependent upon the intact RARE are also
sites where endogenous atRA activity is present as
Fig. 4 Nedd9(RARE)-lacZ and Nedd9(mutRARE)-lacZ
embryos exposed to atRA for 6 h. Pregnant dams were dosed
at E8.25 with either vehicle (a, b, e, f) or atRA (c, d, g, h) 6 h
prior to embryo collection followed by staining for b-gal
activity. Embryos (a–d) are from a Nedd9(RARE)-lacZ mating
and embyos (e–h) are from a Nedd9(mutRARE)-lacZ mating.
Scale bar is 50 lm. Abbreviations pos pre-otic sulcus, os otic
sulcus, ncc pr2 neural crest cells migrating from presumptive
rhomobomere 2, ne neuroepithelium
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assessed using embryos carrying a lacZ reporter
transgene containing multiple copies of the RARb
RARE (b-RARE-lacZ). b-RARE-lacZ expression is
found in the neural plate at the early somite stage
caudal to the preotic sulcus, and by the 8–10 somite
stage, it is found caudal to the otic vesicle extending to
the last formed somite, but is absent or very low in the
tail bud, the most posterior region of the embryo
(McCaffery et al. 1999; Molotkova et al. 2005;
Rossant et al. 1991; Wagner et al. 2000). By E10.5,
the expression of the b-RARE-lacZ transgene in
the trunk is strong in the region of the dorsal spinal
cord and developing ventral motor axons (Mic et al.
2002; Rossant et al. 1991) both regions where the
Nedd9(RARE)-lacZ transgene is expressed. Much of
this b-RARE-driven lacZ signal can be accounted for
by activity of RALDH2, an enzyme responsible for the
final step in atRA synthesis during the early stages of
embryonic development (Kumar et al. 2012; Mic et al.
2002). At the early somite stage, RALDH2 is
expressed in somitic mesoderm and anterior preso-
mitic mesoderm (Niederreither et al. 1997); the
resulting atRA then diffuses to tissues including the
neural plate, and at later stages, to the neural tube, with
b-RARE-driven lacZ signal showing a more rostral
border than that of RALDH2 (Molotkova et al. 2005;
Sirbu and Duester 2006; Smith et al. 2001). Deletion
of the enzymes responsible for catabolizing atRA
(CYP26A1 and CYP26C1) results in defects in the
migrating ncc population supporting the notion that at
least some atRA diffuses into the hindbrain region
(Uehara et al. 2007). RALDH3 also contributes to the
production of atRA in embryos at later stages,
including the developing eye and forebrain (Smith
et al. 2001). It is possible that the lack of overlap in
Nedd9(RARE)-lacZ expression and atRA activity (as
assessed by the b-RARE-lacZ transgene) in some
regions of the developing nervous system, including
the ncc emanating from the hindbrain and the drg, and
later in the optic stalk is due to activation of the Nedd9
transgene at lower concentrations than needed for that
of the b-RARE transgene, or alternatively, the b-
RARE-lacZ could be silenced in these regions.
Nedd9(RARE)-lacZ transgenic and Nedd9(mut-
RARE)-lacZ transgenic embryos differ in their
response to exogenous atRA treatment. While treat-
ment of the Nedd9(RARE)-lacZ embryos results in a
dramatic expansion of expression, no difference in
expression is observed between vehicle and atRA
treatment for any of the Nedd9(mutRARE)-lacZ lines
indicating a requirement for this RARE to respond to
either endogenous or exogenous sources of atRA.
The present work supports the conclusion that a
complex RARE contained within a lacZ transgene
comprised of a 5.2 kb region of the 2B Nedd9
promoter is responsible for driving a large subset of
the endogenous Nedd9 expression pattern including
that in the hindbrain neuroepithelium caudal to the r5
border, spinal cord, drg and migrating neural crest.
However, the transgene does not copy the native
Nedd9 expression in pr3 and pr5 of the early hindbrain,
nor the forebrain telencephalon, indicating that gene
regulatory sequences outside of the 5.2 kb segment are
needed to drive the full complement of Nedd9
expression. Exposure of Nedd9(RARE)-lacZ trans-
genic embryos to excess atRA at E8.25 leads to rostral
ectopic transgene expression within 6 h, confirming
the atRA-responsiveness of the RARE-containing
construct in vivo. In transgenic embryos where the
RARE has been mutated the majority of lacZ expres-
sion is lost. This is observed at every stage analyzed,
indicating that atRA signaling through the Nedd9
RARE is necessary for a significant proportion of
endogenous gene expression during development as
well as for modification of expression by atRA.
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